PRESS RELEASE published on 12/11/2023 at 10:00, 1 year 11 months ago Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited
PRESS RELEASE published on 11/20/2023 at 12:00, 2 years ago Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000
PRESS RELEASE published on 11/02/2023 at 11:00, 2 years 1 month ago Tryp Therapeutics Inc. Announces Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3.0 Million
PRESS RELEASE published on 10/11/2023 at 22:30, 2 years 1 month ago Tryp Therapeutics Announces Closing of Private Placement of Unsecured Convertible Debentures for Gross Proceeds of AUD$175,000
PRESS RELEASE published on 08/03/2023 at 12:00, 2 years 4 months ago Tryp Therapeutics Announces Jason Carroll as New Chief Executive Officer
PRESS RELEASE published on 08/02/2023 at 12:00, 2 years 4 months ago With Great Sadness Tryp Announces the Passing of David Tousley, Director
PRESS RELEASE published on 07/13/2023 at 12:00, 2 years 4 months ago Tryp Therapeutics Receives Confirmation From FDA To Proceed With Phase 2A Clinical Trial in Patients With IBS at Massachusetts General Hospital
PRESS RELEASE published on 05/24/2023 at 12:00, 2 years 6 months ago Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital
PRESS RELEASE published on 04/27/2023 at 12:00, 2 years 7 months ago Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Secured Convertible Debentures for Gross Proceeds of AUD$2,400,000
PRESS RELEASE published on 04/12/2023 at 22:00, 2 years 7 months ago Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
Published on 12/05/2025 at 02:35, 7 hours 1 minute ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 36 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 31 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 36 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:05, 31 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 51 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 36 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 51 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 52 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
